Study to Evaluate DNL201 in Subjects With Parkinson's Disease

Clinical trial NCT03710707 · COMPLETED

Trial details

NCT number: NCT03710707
Sponsor: Denali Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2018-12-04
Primary completion: 2019-12-06
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.